Defective interfering virus

An antiviral drug, influenza A virus technology, applied in the direction of viruses, viral peptides, viral antigen components, etc., can solve the problem of low yield of DI virus

Active Publication Date: 2013-06-26
UNIVERSITY OF WARWICK
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0048] The inventors have tried to produce cloned DI influenza A virus by passaging in embryonated chicken eggs, but the yield of DI virus obtained was too low

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Defective interfering virus
  • Defective interfering virus
  • Defective interfering virus

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0190] Preparation of cloned DI virus

[0191] The methods used in the specific examples are described below and are subject to variation, see also the materials and methods described in Duhaut & Dimmock (2003), supra.

[0192] HEK293T cells were transfected by known methods with the set of plasmids necessary for the preparation of infectious A / PR8 / 34 virus (H1N1).

[0193] The transfected cells are then co-cultured with MDCK cells to amplify infectious virus. Tissue culture fluid containing the infectious virus and any DI virus present was collected, centrifuged at low speed to remove debris, and stored at -70°C. The presence of virus was shown by agglutination of chicken erythrocytes (see below). Virus titers were recorded as hemagglutination units (HAU) per milliliter of virus.

[0194] Tissue culture fluid (500 μl) was then injected into the allantoic cavity of 10-day-old embryonated chicken eggs to boost the concentration of infectious virus and infer the presence of D...

Embodiment 1

[0255] Example 1 - Production of cloned DI virus 220 / PR8

[0256] Previous work known in the art teaches that production of DI virus is optimal when inoculating embryonated chicken eggs with a large inoculum (eg, up to 2 ml per egg). The explanation given is that cells inhabited by non-infectious DI virus also need to receive infectious (helper) virus so that the former can replicate. Furthermore, the presence of DI virus normally increased when passage was repeated two or three times. Eventually, the amount of DI virus produced exceeds the amount of infectious virus present, and overall virus production declines due to the lack of helper virus function.

[0257] Unexpectedly, the inventors found that inoculation of embryonated chicken eggs with routine, i.e., standard amounts of cloned influenza A virus, failed to yield the expected amount of DI virus material; the gap was so large that it affected further laboratory studies, Including in vivo animal studies; not to menti...

Embodiment 2

[0281] Example 2 - Production of protective virus 244 / PR8

[0282] The primary protective RNA used (segment 1; RNA244) was spontaneously generated during transfection / co-cultivation of a plasmid encoding infectious A / PR / 8 / 34 (Subbarao, K. et al. 2003 Virology 305 : 192-200). The DNA mixture for transfection of 293T cells contained 0.5 μg of each of the 8 A / PR8 gene segments (under the control of the Poll promoter), 0.5 μg of various PB1 and PB2 expression plasmids, 0.1 μg of PA expression plasmids, and 1 μg of NP expression plasmids and Fugene (Roche).

[0283]To optimize the transfection of the 244 iRNA plasmid, the 244 RNA was cloned into the Poll expression plasmid pPOLI-SapIT (Subbarao (2003) supra) in order to express the vRNA sense transcript. Different amounts of 244 plasmid (0-0.5 μg) were transfected into 293T cells as described above. After 24 hours, 293T cells were trypsinized, mixed with MDCK cells and replated. Culture supernatants were harvested after 7 day...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
weightaaaaaaaaaa
Login to view more

Abstract

A method for producing a cloned DI influenza A virus comprising: transfecting a cell with (i) a plasmid comprising an RNA segment of an influenza A virus that has a deletion therein and (ii) plasmids which in combination provide RNA segments 1 to 8 of an infectious influenza A virus; culturing the infected cells; introducing an aliquot of less than 100žl of the transfected cell culture medium into an embryonated egg; incubating and recovering virus material from the egg. Also claimed are uses of cloned DI influenza virus as a medicament for the treatment of influenza and isolated nucleic acid molecules encoding genomic segment 1 of a cloned DI influenza virus.

Description

field of invention [0001] The present invention relates to virology and the prevention and / or treatment of viral infections in animals (including birds and humans), especially influenza A. The invention also relates to the field of antiviral therapy. The present invention further relates to a process for the production of interference deficient (DI) viruses, ie "DI viruses", useful as active agents for the prophylaxis and / or treatment of viral infections. A "DI virus" is a defined, usually cloned, "interfering defect" virus. A "interfering virus" is generally a defective virus that interferes with the normal replication and infection cycle of a non-defective virus. (DI influenza virus preparations are known in the art, but there is genetic heterogeneity.) Background technique [0002] Orthomyxoviridae are RNA viruses that infect vertebrates. This family includes those viruses that cause influenza. [0003] Influenza is a viral infection of the respiratory system charact...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K39/145C12N15/09C12N15/44C12N7/04C07K14/11
CPCA61K39/145A61K2039/543A61K2039/525A61K2039/5252C12N2760/16134C12N7/00A61K2039/542A61K39/12
Inventor 奈杰尔·迪默克
Owner UNIVERSITY OF WARWICK
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap